Eli Lilly Shares Jump After GLP-1 Pill Trial Success
Eli Lilly Shares Jump After GLP-1 Pill Trial Success Eli Lilly’s shares surged following the successful results of its phase 3 trial for an oral GLP-1 receptor agonist pill, orforglipron, designed to aid weight loss in people with obesity or overweight conditions. This breakthrough, which demonstrated significant weight reduction without the need for injections, marks […]
Eli Lilly Shares Jump After GLP-1 Pill Trial Success Read More »